vs
Side-by-side financial comparison of Organon & Co. (OGN) and UNIVERSAL CORP (UVV). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $853.2M, roughly 1.8× UNIVERSAL CORP). UNIVERSAL CORP runs the higher net margin — 3.9% vs -13.6%, a 17.5% gap on every dollar of revenue. On growth, Organon & Co. posted the faster year-over-year revenue change (-5.3% vs -8.1%). Organon & Co. produced more free cash flow last quarter ($96.0M vs $95.1M). Over the past eight quarters, UNIVERSAL CORP's revenue compounded faster (6.2% CAGR vs -3.6%).
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.
OGN vs UVV — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $853.2M |
| Net Profit | $-205.0M | $33.2M |
| Gross Margin | 49.2% | 17.8% |
| Operating Margin | -9.8% | 9.6% |
| Net Margin | -13.6% | 3.9% |
| Revenue YoY | -5.3% | -8.1% |
| Net Profit YoY | -288.1% | -44.2% |
| EPS (diluted) | $-0.78 | $1.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5B | $853.2M | ||
| Q3 25 | $1.6B | $749.4M | ||
| Q2 25 | $1.6B | $592.6M | ||
| Q1 25 | $1.5B | $690.2M | ||
| Q4 24 | $1.6B | $928.0M | ||
| Q3 24 | $1.6B | $708.4M | ||
| Q2 24 | $1.6B | $596.4M | ||
| Q1 24 | $1.6B | $756.3M |
| Q4 25 | $-205.0M | $33.2M | ||
| Q3 25 | $160.0M | $34.2M | ||
| Q2 25 | $145.0M | $8.5M | ||
| Q1 25 | $87.0M | $9.3M | ||
| Q4 24 | $109.0M | $59.6M | ||
| Q3 24 | $359.0M | $25.9M | ||
| Q2 24 | $195.0M | $130.0K | ||
| Q1 24 | $201.0M | $40.3M |
| Q4 25 | 49.2% | 17.8% | ||
| Q3 25 | 53.5% | 18.0% | ||
| Q2 25 | 54.8% | 19.1% | ||
| Q1 25 | 55.6% | 15.1% | ||
| Q4 24 | 56.3% | 19.9% | ||
| Q3 24 | 58.3% | 19.9% | ||
| Q2 24 | 58.4% | 16.0% | ||
| Q1 24 | 59.0% | 18.0% |
| Q4 25 | -9.8% | 9.6% | ||
| Q3 25 | 15.2% | 9.0% | ||
| Q2 25 | 14.4% | 5.7% | ||
| Q1 25 | 6.7% | 6.2% | ||
| Q4 24 | 8.1% | 11.2% | ||
| Q3 24 | 13.1% | 9.7% | ||
| Q2 24 | 14.6% | 2.9% | ||
| Q1 24 | 14.5% | 9.0% |
| Q4 25 | -13.6% | 3.9% | ||
| Q3 25 | 10.0% | 4.6% | ||
| Q2 25 | 9.1% | 1.4% | ||
| Q1 25 | 5.8% | 1.4% | ||
| Q4 24 | 6.8% | 6.4% | ||
| Q3 24 | 22.7% | 3.7% | ||
| Q2 24 | 12.1% | 0.0% | ||
| Q1 24 | 12.4% | 5.3% |
| Q4 25 | $-0.78 | $1.32 | ||
| Q3 25 | $0.61 | $1.36 | ||
| Q2 25 | $0.56 | $0.34 | ||
| Q1 25 | $0.33 | $0.37 | ||
| Q4 24 | $0.42 | $2.37 | ||
| Q3 24 | $1.38 | $1.03 | ||
| Q2 24 | $0.75 | $0.01 | ||
| Q1 24 | $0.78 | $1.62 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $574.0M | $85.2M |
| Total DebtLower is stronger | $8.6B | — |
| Stockholders' EquityBook value | $752.0M | $1.5B |
| Total Assets | $12.9B | $3.0B |
| Debt / EquityLower = less leverage | 11.49× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $574.0M | $85.2M | ||
| Q3 25 | $672.0M | $88.7M | ||
| Q2 25 | $599.0M | $178.4M | ||
| Q1 25 | $547.0M | $260.1M | ||
| Q4 24 | $675.0M | $215.1M | ||
| Q3 24 | $763.0M | $80.1M | ||
| Q2 24 | $704.0M | $101.7M | ||
| Q1 24 | $575.0M | $55.6M |
| Q4 25 | $8.6B | — | ||
| Q3 25 | $8.8B | — | ||
| Q2 25 | $8.9B | — | ||
| Q1 25 | $9.0B | — | ||
| Q4 24 | $8.9B | — | ||
| Q3 24 | $8.7B | — | ||
| Q2 24 | $8.7B | — | ||
| Q1 24 | $8.7B | — |
| Q4 25 | $752.0M | $1.5B | ||
| Q3 25 | $906.0M | $1.5B | ||
| Q2 25 | $733.0M | $1.5B | ||
| Q1 25 | $542.0M | $1.5B | ||
| Q4 24 | $472.0M | $1.5B | ||
| Q3 24 | $493.0M | $1.4B | ||
| Q2 24 | $144.0M | $1.4B | ||
| Q1 24 | $48.0M | $1.4B |
| Q4 25 | $12.9B | $3.0B | ||
| Q3 25 | $13.6B | $3.1B | ||
| Q2 25 | $13.5B | $3.2B | ||
| Q1 25 | $13.2B | $3.0B | ||
| Q4 24 | $13.1B | $3.0B | ||
| Q3 24 | $12.8B | $3.0B | ||
| Q2 24 | $12.2B | $3.0B | ||
| Q1 24 | $11.9B | $2.9B |
| Q4 25 | 11.49× | — | ||
| Q3 25 | 9.74× | — | ||
| Q2 25 | 12.14× | — | ||
| Q1 25 | 16.52× | — | ||
| Q4 24 | 18.81× | — | ||
| Q3 24 | 17.75× | — | ||
| Q2 24 | 60.11× | — | ||
| Q1 24 | 181.54× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $141.0M | $114.3M |
| Free Cash FlowOCF − Capex | $96.0M | $95.1M |
| FCF MarginFCF / Revenue | 6.4% | 11.1% |
| Capex IntensityCapex / Revenue | 3.0% | 2.3% |
| Cash ConversionOCF / Net Profit | — | 3.44× |
| TTM Free Cash FlowTrailing 4 quarters | $538.0M | $52.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $141.0M | $114.3M | ||
| Q3 25 | $264.0M | $32.7M | ||
| Q2 25 | $220.0M | $-205.1M | ||
| Q1 25 | $75.0M | $158.7M | ||
| Q4 24 | $390.0M | $215.6M | ||
| Q3 24 | $141.0M | $15.0M | ||
| Q2 24 | $332.0M | $-62.4M | ||
| Q1 24 | $76.0M | $-27.9M |
| Q4 25 | $96.0M | $95.1M | ||
| Q3 25 | $218.0M | $23.7M | ||
| Q2 25 | $181.0M | $-217.2M | ||
| Q1 25 | $43.0M | $151.0M | ||
| Q4 24 | $335.0M | $199.6M | ||
| Q3 24 | $99.0M | $-1.0M | ||
| Q2 24 | $300.0M | $-85.2M | ||
| Q1 24 | $30.0M | $-46.2M |
| Q4 25 | 6.4% | 11.1% | ||
| Q3 25 | 13.6% | 3.2% | ||
| Q2 25 | 11.4% | -36.6% | ||
| Q1 25 | 2.8% | 21.9% | ||
| Q4 24 | 21.0% | 21.5% | ||
| Q3 24 | 6.3% | -0.1% | ||
| Q2 24 | 18.7% | -14.3% | ||
| Q1 24 | 1.8% | -6.1% |
| Q4 25 | 3.0% | 2.3% | ||
| Q3 25 | 2.9% | 1.2% | ||
| Q2 25 | 2.4% | 2.0% | ||
| Q1 25 | 2.1% | 1.1% | ||
| Q4 24 | 3.5% | 1.7% | ||
| Q3 24 | 2.7% | 2.3% | ||
| Q2 24 | 2.0% | 3.8% | ||
| Q1 24 | 2.8% | 2.4% |
| Q4 25 | — | 3.44× | ||
| Q3 25 | 1.65× | 0.96× | ||
| Q2 25 | 1.52× | -24.14× | ||
| Q1 25 | 0.86× | 17.00× | ||
| Q4 24 | 3.58× | 3.62× | ||
| Q3 24 | 0.39× | 0.58× | ||
| Q2 24 | 1.70× | -480.34× | ||
| Q1 24 | 0.38× | -0.69× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OGN
Segment breakdown not available.
UVV
| Tobacco Operations | $779.9M | 91% |
| Service Other | $36.7M | 4% |
| Other | $17.8M | 2% |
